JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 17, Issue 1 (2025)
Iran J War Public Health 2025, 17(1): 75-82 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2025/03/11 | Accepted: 2025/04/16 | Published: 2025/04/21
Received: 2025/03/11 | Accepted: 2025/04/16 | Published: 2025/04/21
How to cite this article
Abbas O, Mohammed A. Bacterial Resistance to Disinfectants in Hospitals of the Medical City, Baghdad, Iraq. Iran J War Public Health 2025; 17 (1) :75-82
URL: http://ijwph.ir/article-1-1572-en.html
URL: http://ijwph.ir/article-1-1572-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
O.T. Abbas *1, A.J. Mohammed1
1- Department of Biology, Faculty of Science, University of Baghdad, Baghdad, Iraq
Abstract (187 Views)
Aims: Biofilm formation by bacteria causing healthcare-associated infections poses significant challenges in healthcare and clinical environmental settings, as these biofilms contribute to the emergence of antimicrobial resistance, chronic infections, and contamination of medical equipment, complicating infection control and sanitation strategies. This study investigated the biofilm development of Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Burkholderia cepacia following exposure to three disinfectant formulations at different concentrations.
Materials & Methods: This experimental study was done on 40 bacterial isolates collected from various hospital surfaces and medical equipment from different hospitals in Medical City in Baghdad. The first disinfectant comprised 45% ethyl alcohol, 5% isopropyl alcohol, and dodecyl dimethyl ammonium chloride. The second formulation included quaternary ammonium propionate, chlorhexidine digluconate, and a 2% glutaraldehyde solution. The third consisted of 10% dodecyl dimethyl ammonium chloride and 2% benzalkonium chloride. Biofilm formation was assessed using the Crystal Violet assay. Data were analyzed by SPSS 20.
Findings: Most bacterial strains exhibited moderate to strong biofilm formation across all treatments, with some instances of weak biofilm development noted after the application of the second disinfectant. This suggests that disinfectant efficacy against biofilm-associated bacteria remains limited.
Conclusion: Most bacterial strains exhibit moderate to strong biofilm formation across all treatments.
Materials & Methods: This experimental study was done on 40 bacterial isolates collected from various hospital surfaces and medical equipment from different hospitals in Medical City in Baghdad. The first disinfectant comprised 45% ethyl alcohol, 5% isopropyl alcohol, and dodecyl dimethyl ammonium chloride. The second formulation included quaternary ammonium propionate, chlorhexidine digluconate, and a 2% glutaraldehyde solution. The third consisted of 10% dodecyl dimethyl ammonium chloride and 2% benzalkonium chloride. Biofilm formation was assessed using the Crystal Violet assay. Data were analyzed by SPSS 20.
Findings: Most bacterial strains exhibited moderate to strong biofilm formation across all treatments, with some instances of weak biofilm development noted after the application of the second disinfectant. This suggests that disinfectant efficacy against biofilm-associated bacteria remains limited.
Conclusion: Most bacterial strains exhibit moderate to strong biofilm formation across all treatments.
Keywords:
References
1. Ntelezos K, Karavasili M, Kyriakopoulou G, Delitzakis D, Giannakas AM, Vergadou C. Comparative study of disinfectants' management in hospitals of Greece and Cyprus. Sci Chron. 2020;25(2):358. [Link]
2. Boyce JM. Quaternary ammonium disinfectants and antiseptics: Tolerance, resistance and potential impact on antibiotic resistance. Antimicrob Resist Infect Control. 2023;12(1):32. [Link] [DOI:10.1186/s13756-023-01241-z]
3. Muhammad MH, Idris AL, Fan X, Guo Y, Yu Y, Jin X, et al. Beyond risk: Bacterial biofilms and their regulating approaches. Front Microbiol. 2020;11:928. [Link] [DOI:10.3389/fmicb.2020.00928]
4. Maillard JY, Centeleghe I. How biofilm changes our understanding of cleaning and disinfection. Antimicrob Resist Infect Control. 2023;12(1):95. [Link] [DOI:10.1186/s13756-023-01290-4]
5. Pagedar A, Singh J, Batish VK. Adaptation to benzalkonium chloride and ciprofloxacin affects biofilm formation potential, efflux pump and haemolysin activity of Escherichia coli of dairy origin. J Dairy Res. 2012;79(4):383-9. [Link] [DOI:10.1017/S0022029912000295]
6. Vishwakarma V. Impact of environmental biofilms: Industrial components and its remediation. J Basic Microbiol. 2020;60(3):198-206. [Link] [DOI:10.1002/jobm.201900569]
7. Jiao Y, Tay FR, Niu LN, Chen JH. Advancing antimicrobial strategies for managing oral biofilm infections. International journal of oral science. 2019;11(3):28. [Link] [DOI:10.1038/s41368-019-0062-1]
8. Pires DP, Melo LD, Boas DV, Sillankorva S, Azeredo J. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Current opinion in microbiology. 2017;39:48-56. [Link] [DOI:10.1016/j.mib.2017.09.004]
9. Gaikwad UN, Basak S, Kulkarni P, Sande S, Cahavan S, Mudey G, Tankhiwale NS, Fule RP, Gaikwad NR. Educational intervention to foster best infection control practices among nursing staff. Int J Infect. 2018;5(3):e81531. [Link] [DOI:10.5812/iji.81531]
10. O'grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II. Guidelines for the prevention of intravascular catheter-related infections. Clinical infectious diseases. 2011;52(9):e162-93. [Link] [DOI:10.1093/cid/cir257]
11. Finšgar M, Uzunalić AP, Stergar J, Gradišnik L, Maver U. Novel chitosan/diclofenac coatings on medical grade stainless steel for hip replacement applications. Sci Rep. 2016;6:26653. [Link] [DOI:10.1038/srep26653]
12. Toyofuku M, Inaba T, Kiyokawa T, Obana N, Yawata Y, Nomura N. Environmental factors that shape biofilm formation. Biosci Biotechnol Biochem. 2016;80(1):7-12. [Link] [DOI:10.1080/09168451.2015.1058701]
13. Preda VG, Săndulescu O. Communication is the key: Biofilms, quorum sensing, formation and prevention. Discoveries. 2019;7(3):e100. [Link] [DOI:10.15190/d.2019.13]
14. Bureš F. Quaternary ammonium compounds: Simple in structure, complex in application. Top Curr Chem. 2019;377(3):14. [Link] [DOI:10.1007/s41061-019-0239-2]
15. Dvorak G. Disinfection 101. Ames: The Center for Food Security and Public Health; 2008. [Link]
16. Mehmood MD, Sabir S, Ghani MU, Ul-Haq HA, Khalid R, Sharif N. An assessment of various disinfectants using the Kirby-Bauer Method with disc diffusion to determine their effectiveness against locally isolated pathogens. J Drug Deliv Ther. 2024;14(6):143-9. [Link] [DOI:10.22270/jddt.v14i6.6612]
17. Pena SA, Salas JG, Gautam N, Ramos AM, Frantz AL. Sublethal exposure to common benzalkonium chloride leads to antimicrobial tolerance and antibiotic cross-resistance in commensal and opportunistic bacterial species. Appl Microbiol. 2023;3(2):580-91. [Link] [DOI:10.3390/applmicrobiol3020041]
18. Yeung W, Ma Y, Liu Y, Pun H, Chua L. Prevalence of alcohol-tolerant and antibiotic-resistant bacterial pathogens on public hand sanitizer dispensers. J Hosp Infect. 2022;127:26-33. [Link] [DOI:10.1016/j.jhin.2022.05.017]
19. Hassanain T, Alyaa R, Ahmad R, Nadia Z, Syakirah H, Nur M. Effectiveness of commonly used antiseptics on bacteria causing nosocomial infections in tertiary hospital in Malaysia. Afr J Microbiol Res. 2019;13(10):188-94. [Link]
20. Denysko TV, Nazarchuk OA, Gruzevskyi O, Bahniuk NÀ, Dmytriiev DV, Chornopyschuk RM, et al. In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds. Front Microbiol. 2022;13:932467. [Link] [DOI:10.3389/fmicb.2022.932467]
21. Rozman U, Pušnik M, Kmetec S, Duh D, Šostar Turk S. Reduced susceptibility and increased resistance of bacteria against disinfectants: A systematic review. Microorganisms. 2021;9(12):2550. [Link] [DOI:10.3390/microorganisms9122550]
22. Caselli E, Brusaferro S, Coccagna M, Arnoldo L, Berloco F, Antonioli P, et al. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study. PLoS One. 2018;13(7):e0199616. [Link] [DOI:10.1371/journal.pone.0199616]
23. Hashem YA, Abdelrahman KA, Aziz RK. Phenotype-genotype correlations and distribution of key virulence factors in enterococcus faecalis isolated from patients with urinary tract infections. Infect Drug Resist. 2021;14:1713-23. [Link] [DOI:10.2147/IDR.S305167]
24. Singh AK, Prakash P, Achra A, Singh GP, Das A, Singh RK. Standardization and classification of in vitro biofilm formation by clinical isolates of Staphylococcus aureus. J Glob Infect Dis. 2017;9(3):93-101. [Link] [DOI:10.4103/jgid.jgid_91_16]
25. Biedenbach DJ, Giao PT, Hung Van P, Su Minh Tuyet N, Thi Thanh Nga T, Phuong DM, et al. Antimicrobial-resistant Pseudomonas aeruginosa and acinetobacter baumannii from patients with hospital-acquired or ventilator-associated pneumonia in Vietnam. Clin Ther. 2016;38(9):2098-105. [Link] [DOI:10.1016/j.clinthera.2016.07.172]
26. Elkheloui R, Laktib A, Mimouni R, Aitalla A, Hassi M, Elboulani A, et al. Acinetobacter baumannii Biofilm: Intervening factors, persistence, drug resistance, and strategies of treatment. Mediterr J Infect Microbes Antimicrob. 2020;9(1):7. [Link] [DOI:10.4274/mjima.galenos.2020.2020.7]
27. Lompo P, Heroes AS, Agbobli E, Kühne V, Tinto H, Affolabi D, et al. Bacterial contamination of antiseptics, disinfectants and hand hygiene products in healthcare facilities in high-income countries: A scoping review. Hygiene. 2023;3(2):136-75. [Link] [DOI:10.3390/hygiene3020012]
28. Ogunsola FT, Mehtar S. Challenges regarding the control of environmental sources of contamination in healthcare settings in low-and middle-income countries-A narrative review. Antimicrob Resist Infect Control. 2020;9(1):81. [Link] [DOI:10.1186/s13756-020-00747-0]
29. Lompo P, Heroes AS, Ouédraogo K, Okitale P, Wakpo A, Kalema J, et al. Knowledge, awareness, and risk practices related to bacterial contamination of antiseptics, disinfectants, and hand hygiene products among healthcare workers in sub-saharan Africa: A cross-sectional survey in three tertiary care hospitals (Benin, Burkina Faso, and DR Congo). Antimicrob Resist Infect Control. 2024;13(1):441. [Link] [DOI:10.1186/s13756-024-01396-3]
30. Mougin J, Midelet G, Leterme S, Best G, Ells T, Joyce A, et al. Benzalkonium chloride disinfectant residues stimulate biofilm formation and increase survival of vibrio bacterial pathogens. Front Microbiol. 2024;14:1309032. [Link] [DOI:10.3389/fmicb.2023.1309032]
31. Strempel N, Nusser M, Neidig A, Brenner-Weiss G, Overhage J. The oxidative stress agent hypochlorite stimulates c-di-GMP synthesis and biofilm formation in pseudomonas aeruginosa. Front Microbiol. 2017;8:2311. [Link] [DOI:10.3389/fmicb.2017.02311]
32. Van Dijk HFG, Verbrugh HA, Ad Hoc Advisory Committee on Disinfectants of the Health Council of the Netherlands. Resisting disinfectants. Commun Med. 2022;2:6. [Link] [DOI:10.1038/s43856-021-00070-8]
33. Rakshit P, Singh A, Singh R, Banerjee T. An in-depth study on survival mechanism of bacterial isolates in disinfectants within the hospital environment. Front Cell Infect Microbiol. 2024;14:1442914. [Link] [DOI:10.3389/fcimb.2024.1442914]
34. Dynes JJ, Lawrence JR, Korber DR, Swerhone GD, Leppard GG, Hitchcock AP. Morphological and biochemical changes in pseudomonas fluorescens biofilms induced by sub-inhibitory exposure to antimicrobial agents. Can J Microbiol. 2009;55(2):163-78. [Link] [DOI:10.1139/W08-109]
35. Russell AD. Bacterial resistance to disinfectants: Present knowledge and future problems. J Hosp Infect. 1999;43(Suppl 1):S57-68. [Link] [DOI:10.1016/S0195-6701(99)90066-X]
36. Meena S, Bir R, Sood S, Das BK, Kapil A. Emergence of Burkholderia cepacia in ICU setting. Indian J Crit Care Med. 2019;23(9):423-6. [Link] [DOI:10.5005/jp-journals-10071-23237]
37. Tavares M, Kozak M, Balola A, Sá-Correia I. Burkholderia cepacia complex bacteria: A feared contamination risk in water-based pharmaceutical products. Clin Microbiol Rev. 2020;33(3):e00139-19. [Link] [DOI:10.1128/CMR.00139-19]
38. Ababneh Q, Abulaila S, Jaradat Z. Isolation of extensively drug resistant acinetobacter baumannii from environmental surfaces inside intensive care units. Am J Infect Control. 2022;50(2):159-65. [Link] [DOI:10.1016/j.ajic.2021.09.001]